Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Morris

Showing results (171-180 of 435) with videos related to

Pageof 44
Sort By:
Journal of Surgical Oncology|June 6, 2013
Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastasesTerence C Chua, Liam E Quinn, Jing Zhao, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 7, 2019
Long term survival and perioperative propensity score matched outcomes in diaphragmatic interventions in cytoreductive surgery + intra-peritoneal chemotherapyBhavneet Singh, Gurkirat Singh, Nayef Alzahrani, et al.
Anticancer Research|January 25, 2023
Comparing Survival Outcomes and Impact of EPIC in Patients Undergoing CRS/HIPEC for Mucinous Appendiceal NeoplasmMelanie Mercado, Raphael Shamavonian, Ernest Cheng, et al.
Hepatic Oncology|September 8, 2018
Current role of transarterial chemoembolization and radioembolization in the treatment of metastatic colorectal cancerLourens Bester, Baerbel Meteling, David Boshell, et al.
Biomacromolecules|January 27, 2012
Effect of cross-linking on the performance of micelles as drug delivery carriers: a cell uptake studyYoseop Kim, Mohammad H Pourgholami, David L Morris, et al.
Cancer Management and Research|December 11, 2012
Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacyDaniel L Chan, David L Morris, Archana Rao, et al.
Annals of Surgical Oncology|May 14, 2024
ASO Author Reflections: Innovative HIPEC Organoid Models and Mucolytics: Targeted Therapeutic Use of Bromelain for Appendiceal CancerRichard A Erali, Nadeem Wajih, David L Morris, et al.
International Journal of Surgical Oncology|July 14, 2012
Approach to rectal cancer surgeryTerence C Chua, Chanel H Chong, Winston Liauw, et al.
International Journal of Surgery Case Reports|April 10, 2022
Case series on high grade appendiceal cancer with peritoneal and liver carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)Susmit Prosun Roy, Nayef Al Zhahrani, Shoma Barat, et al.
Diseases of the Colon and Rectum|March 8, 2017
Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal DisseminationYeqian Huang, Nayef A Alzahrani, Terence C Chua, et al.
Pageof 44

Showing results (171-180 of 435) with videos related to

Sort By:
Pageof 44
Journal of Surgical Oncology|June 6, 2013
Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastasesTerence C Chua, Liam E Quinn, Jing Zhao, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 7, 2019
Long term survival and perioperative propensity score matched outcomes in diaphragmatic interventions in cytoreductive surgery + intra-peritoneal chemotherapyBhavneet Singh, Gurkirat Singh, Nayef Alzahrani, et al.
Anticancer Research|January 25, 2023
Comparing Survival Outcomes and Impact of EPIC in Patients Undergoing CRS/HIPEC for Mucinous Appendiceal NeoplasmMelanie Mercado, Raphael Shamavonian, Ernest Cheng, et al.
Hepatic Oncology|September 8, 2018
Current role of transarterial chemoembolization and radioembolization in the treatment of metastatic colorectal cancerLourens Bester, Baerbel Meteling, David Boshell, et al.
Biomacromolecules|January 27, 2012
Effect of cross-linking on the performance of micelles as drug delivery carriers: a cell uptake studyYoseop Kim, Mohammad H Pourgholami, David L Morris, et al.
Cancer Management and Research|December 11, 2012
Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacyDaniel L Chan, David L Morris, Archana Rao, et al.
Annals of Surgical Oncology|May 14, 2024
ASO Author Reflections: Innovative HIPEC Organoid Models and Mucolytics: Targeted Therapeutic Use of Bromelain for Appendiceal CancerRichard A Erali, Nadeem Wajih, David L Morris, et al.
International Journal of Surgical Oncology|July 14, 2012
Approach to rectal cancer surgeryTerence C Chua, Chanel H Chong, Winston Liauw, et al.
International Journal of Surgery Case Reports|April 10, 2022
Case series on high grade appendiceal cancer with peritoneal and liver carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)Susmit Prosun Roy, Nayef Al Zhahrani, Shoma Barat, et al.
Diseases of the Colon and Rectum|March 8, 2017
Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal DisseminationYeqian Huang, Nayef A Alzahrani, Terence C Chua, et al.
Pageof 44